Keywords
dermatological manifestations
infectious hypothesis
psychiatric hypothesis
diagnostics
treatment
stigmatization
telemedicine
artificial intelligence
How to Cite
Abstract
Morgellons disease is a rare and controversial disease. It combines dermatological, infectious, and psychiatric manifestations. It is characterized by the formation of skin lesions with filaments emanating from the tissues. Also, by sensory phenomena in the form of a crawling or stinging sensation under the skin. As well as systemic symptoms, including chronic fatigue and cognitive disorders. The article analyzes the literature and clinical reports that highlight the infectious and psychiatric hypotheses, morphological and biochemical features, sociocultural factors, and problems of diagnosis and treatment. It is established that Morgellons disease remains uncertain in the nosological classification, which complicates the creation of unified approaches to its management. At the same time, the need for a multidisciplinary, multisystemic approach that integrates dermatology, infectious diseases, biochemistry, microbiology, clinical diagnostics, immunology, psychiatry, and psychology is emphasized. The conclusion is made about the urgent need for conducting systematic studies of etiology and pathogenesis, developing standardized diagnostic criteria and therapeutic protocols, as well as overcoming the stigmatization of patients. The help of artificial intelligence opens new opportunities for early diagnosis of Morgellons disease through the analysis of large arrays of clinical and laboratory data, recognition of dermatological images and prediction of the course of the disease. The use of machine learning algorithms contributes to more accurate differential diagnosis between infectious, dermatological, and psychiatric manifestations, which helps to minimize false diagnoses. The use of artificial intelligence in telemedicine and clinical practice of Morgellons disease allows for a personalized approach to treatment, optimizing the choice of therapeutic strategies and monitoring the effectiveness of treatment. The integration of artificial intelligence technologies into research and clinical practice is considered a promising direction for overcoming diagnostic and therapeutic difficulties in Morgellons disease.
References
1. Pearson M. L., Selby J. V., Katz K. A. et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012. Vol. 7. No. 1. e29908. DOI: https://doi.org/10.1371/journal.pone.0029908
2. Middelveen M. J., Fesler M. C., Stricker R. B. History of Morgellons disease: from delusion to definition. Clinical, Cosmetic and Investigational Dermatology. 2018. Vol. 11. P. 71–90. DOI: https://doi.org/10.2147/CCID.S152343
3. Kemperman P. M. J. H., Vulink N. C. C., Smit C. et al. Review of literature and clinical practice experience for the therapeutic management of Morgellons disease. Journal of the European Academy of Dermatology and Venereology. 2024. Vol. 38. Iss. 7. P. 1300–1304. DOI: https://doi.org/10.1111/jdv.19831.
4. Jalbout J., Sati H., Ghalloub P. et al. Morgellons disease: a narrative review. Neurological Sciences. 2024. Vol. 45. No. 6. P. 2579–2591. DOI: https://doi.org/10.1007/s10072-024-07361-7.
5. Blay J., Costes V., Bernard Guillot B. et al. Post Laser-amelanotic pattern of lentigo maligna: pitfalls in diagnosis and treatment of pigmented facial lesions of unknown nature. Journal of Clinical & Experimental Dermatology Research. 2012. Vol. 3. Iss.5. DOI: https://doi.org/10.4172/2155-9554.1000161.
6. Savely V., Leitao M., Stricker R. The mystery of Morgellons disease: infection or delusion? American Journal of Clinical Dermatology. 2006. Vol. 7. Iss. 1. P. 1-5. DOI:10.2165/00128071-200607010-00001
7. Harvey W., Bransfield R., Mercer D. et al. Morgellons disease, illuminating an undefined illness: a case series. Journal of Medical Case Reports. 2009. No. 3. P. 8243. DOI:10.4076/1752-1947-3-8243
8. Middelveen M.J., Rasmussen E.H., Kahn D.G. et al. Morgellons disease: a chemical and light microscopic study. Journal of Clinical & Experimental Dermatology Research. 2012. Vol. 3. Iss. 1. P. 1-8. DOI: https://doi.org/10.4172/2155-9554.1000140
9. Savely V., Stricker R. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clinical, cosmetic and investigational dermatology. 2010. No.3. P. 67-78. DOI: https://doi.org/10.2147/ccid.s9520
10. Dermatology Nurses' Association. Morgellons disease: a mysterious disease. Dermatology Advisor. 2022. November 7. URL: https://www.dermatologytimes.com/view/morgellons-disease-a-mysterious-disease
11. Middelveen M., Stricker R. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clinical, Cosmetic and Investigational Dermatology. 2011. No. 4. P. 167-177. doi: https://doi.org/10.2147/CCID.S26183
12. Chun-Yeung Y. Etiology of Yan (Morgellons) disease: a new plant-like infectious organism from Brazil and its skin manifestations. Clinical Medicine Insights: Dermatology (en-usa). 2012. No. 5. P. 13—20. DOI: https://doi.org/10.4137/CMD.S9496
13. Chernysh E.V., Plekhov V.A. Morgellons disease is a new infectious disease. Materials of Zaporizhzhya State Medical University. 2016. URL: https://dspace.zsmu.edu.ua/bitstream/123456789/5553/1/2016_SAMF_134.pdf
14. Wymore R.S. Statement of Morgellons disease: Center for the investigation of Morgellons disease. URL: https://www.thenmo.org/
15. Andreychyn M., Bighunyak V., Demyanenko V. The mysterious Morgellons disease. Clinical Immunology, Allergology, Infectology. 2010. No. 5-6. P. 34-35. URL: https://kiai.com.ua/ua/archive/2010/5-6%2834-35%29/pages-5-10/taiemnicha-hvoroba-morgeloniv
16. Harvey W.T., Bransfield. R.C., Mercer D.E. et al. Morgellons disease, illuminating an undefined illness: a case series. Journal of Medical Case Reports. 2009. No. 3. P. 8243. DOI: https://doi.org/10.4076/1752-1947-3-8243
17. Grimson M.J., Higler C.H., Blanton R.L. Cellulose microfibrils, cell motility, and plasma membrane protein organization change in parallel during in culmination in Dictyostelium discoideum. Journal of cell Science. 1996. No. 109. P. 3079-3087. URL: https://pubmed.ncbi.nlm.nih.gov/9004042/
18. Kellett C: Sir Thomas Browne and the Disease called the Morgellons. Annals of Medical History. 1935. Vol. 7. Iss. 5. P. 467-479. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7942326/
19. Wikipedia contributors. Morgellons. Wikipedia. The Free Encyclopedia. Last modified 25.08.2025. URL: https://en.wikipedia.org/wiki/Morgellons
20. Savely V., Stricker R. Morgellons disease: the mystery unfolds. Expert Review of Dermatology. 2014. Vol. 2. Iss. 5. P. 585-591. https://doi.org/10.1586/17469872.2.5.585.
21. Bottaro A. Rare skin diseases. Verywell Health. 2024. URL: https://www.verywellhealth.com/rare-skin-diseases-5096005
22. Jungyoon O., Seon P., Jungyoon M. et al. Morgellons disease. Annals of Dermatology. 2017. Vol. 29. Iss. 2. P.223-225. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5383751/
23. Robles D., Olson J., Combs H. Et al. Morgellons disease and delusions of parasitosis. Am J Clin Dermatol. 2011. No.12. P.1–6. DOI: https://doi.org/10.5021/ad.2017.29.2.223
24. Wikipedia contributors. Delusional parasitosis. Wikipedia, The Free Encyclopedia. Last modified 25.08.2025. URL:https://en.wikipedia.org/wiki/Delusional_parasitosis
25. Savely V., Leitao M., Stricker R. The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol. 2006. Vol.7. Iss. 1. P.1-5. DOI: https://doi.org/10.2165/00128071-200607010-00001
26. Naidoo A., Lepping P., Tan E. Morgellons disease. DermNet NZ. 2024. URL: https://dermnetnz.org/topics/morgellons-disease
27. Söderfeldt Y, Groß D. Information, consent and treatment of patients with Morgellons disease: an ethical perspective. Am J Clin Dermatol. 2014. No.15. P. 71-76. DOI: https://doi.org/10.1007/s40257-014-0071-y
28. Wildner M. Kennen Sie Morgellonen? Gesundheitswesen. 2009. No. 71. P. 795-796. DOI: https://doi.org/10.1055/s-0029-1242727
29. Wong J.W., Koo J.Y. Delusions of parasitosis. Indian J Dermatol. 2013. No. 58. P. 49-52. DOI: https://doi.org/10.4103/0019-5154.105309
30. Hylwa S.A., Foster A.A., Bury J.E. et al. Delusional infestation is typically comorbid with other psychiatric diagnoses: review of 54 patients receiving psychiatric evaluation at Mayo Clinic. Psychosomatics. 2012. Vol. 53. Iss.3. P. 258-265. DOI: https://doi.org/10.1016/j.psym.2011.11.003.
31. Gartner A.M., Dolan S.L., Stanford M.S. et al. Hypnosis in the treatment of Morgellons disease: a case study. Int J Clin Exp Hypn. 2011. Vol. 59. Iss. 2. P. 242-249. DOI: https://doi.org/10.1080/00207144.2011.546263.
32. Reid E.E., Lio P.A. Successful treatment of Morgellons disease with pimozide therapy. Arch Dermatol. 2010. Vol. 146. Iss. 10. 1191-1193. DOI: https://doi.org/10.1001/archdermatol.2010.276.
33. Middelveen M.J., Mayne P.J., Kahn D.G. et al. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013. No. 6. P. 1-21. DOI: https://doi.org/10.2147/CCID.S39017.
34. Salinas M. P., Sepúlveda J., Hidalgo L. et al. A systematic review and meta-analysis of artificial intelligence versus clinicians for skin cancer diagnosis. npj Digital Medicine. 2024. Vol. 7. P. 125. DOI: https://doi.org/10.1038/s41746-024-01103-x
35. Roy G., Prifti E., Belda E. et al. Deep learning methods in metagenomics: a review. Microbial Genomics. 2024. Vol. 10. Iss. 4. P. 001231. DOI: https://doi.org/10.1099/mgen.0.001231
36. Wojtara M., Rana E., Rahman T. et al. Artificial intelligence in rare disease diagnosis and treatment. Clinical and Translational Science. 2023. Vol. 16. P. 2106–2111. DOI: https://doi.org/10.1111/cts.13619
37. Spies E., Flynn J.A., Oliveira N.G. et al. Artificial intelligence-enabled social media listening to inform early patient-focused drug development: perspectives on approaches and strategies. Frontiers in Digital Health. 2024. Vol. 6. P. 1459201. DOI: https://doi.org/10.3389/fdgth.2024.1459201
38. Shapovalova V. Telemedicine and Telepharmacy in Modern Healthcare: Innovations, Medical Technologies, Digital Transformation. SSP Modern Pharmacy and Medicine. 2025. Vol.5. Iss. 3. P.1-19. URL: https://doi.org/10.53933/r7f5xj91
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Viktoriia Shapovalova (Author)